Lonza Group AG
LONN.SW
| Exchange: | SW |
| Currency | Swiss Franc |
| Open Figi: | BBG000NQXR55 |
| ISIN: | CH0013841017 |
| LEI: | 549300EFW4H2TCZ71055 |
| Primary Ticker: | LONN.SW |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Diagnostics & Research |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Biotechnology |
| Gic Sub Industry: | Biotechnology |
| Description: | Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland. |
| Address: | Muenchensteinerstrasse 38, Basel, Switzerland, 4002 |
| Website: | https://www.lonza.com |
| Full Time Employees: | 17834 |
| Updated On: | 2024-11-04 |
Highlights
| Market Capitalization: | 39116046336 |
| Market Capitalization Mln: | 39116.04 |
| EBITDA: | 1840000000 |
| PE Ratio: | 68.14 |
| PEG Ratio: | 1.20 |
| Wall Street Target Price: | 715.25 |
| Book Value: | 131.02 |
| Dividend Share: | 4 |
| Earnings Share: | 7.96 |
| EPS Estimate Current Year: | 15.19 |
| EPS Estimate Next Year: | 18.03 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | 0.08 |
| Operating Margin TTM: | 0.18 |
| Return On Assets TTM: | 0.04 |
| Return On Equity TTM: | 0.05 |
| Revenue TTM: | 6696000000 |
| Revenue Per Share TTM: | 92.60 |
| Quarterly Revenue Growth YOY: | -0.00 |
| Gross Profit TTM: | 2438000000 |
| Diluted Eps TTM: | 7.96 |
| Quarterly Earnings Growth YOY: | -0.16 |
Valuation
| Trailing PE: | 68.14 |
| Forward PE: | 32.05 |
| Price Sales TTM: | 5.84 |
| Price Book MRQ: | 4.18 |
| Enterprise Value: | 40894037873 |
| Enterprise Value Revenue: | 6.10 |
| Enterprise Value Ebitda: | 50.42 |
Shares
| Shares Outstanding: | 72116600 |
| Shares Float: | 71332338 |
| Percent Insiders: | 0.05 |
| Percent Institutions: | 56.11 |
Technicals
| Beta: | 0.65 |
| 52 Week High: | 589.4 |
| 52 Week Low: | 313.20 |
| 50 Day MA: | 540.82 |
| 200 Day MA: | 512.00 |
Splits & Dividends
| Forward Annual Dividend Rate: | 4 |
| Payout Ratio: | 0.50 |
| Dividend Date: | 2024-05-15 |
| Ex Dividend Date: | 2024-05-13 |
| Last Split Factor: | 407:377 |
| Last Split Date: | 2017-05-02 |
Earnings
| Report Date: | 2025-05-08 |
| Date: | 2025-03-31 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Report Date: | 2025-01-29 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Report Date: | 2024-05-14 |
| Date: | 2024-03-31 |
| Before After Market: | After Market |
| Currency: | CHF |
| Report Date: | 2023-10-24 |
| Date: | 2023-09-30 |
| Currency: | CHF |
| Eps Estimate: | 8.44 |
| Eps Difference: | -8.44 |
| Surprise Percent: | -10 |
| Report Date: | 2023-07-21 |
| Date: | 2023-06-30 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Eps Estimate: | 8.32 |
| Eps Difference: | -8.32 |
| Surprise Percent: | -10 |
| Report Date: | 2023-04-20 |
| Date: | 2023-03-31 |
| Currency: | CHF |
| Report Date: | 2023-01-25 |
| Date: | 2022-12-31 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Eps Actual: | 16.34 |
| Eps Estimate: | 8.59 |
| Eps Difference: | 7.75 |
| Surprise Percent: | 90.22 |
| Report Date: | 2022-10-25 |
| Date: | 2022-09-30 |
| Currency: | CHF |
| Report Date: | 2022-07-22 |
| Date: | 2022-06-30 |
| Before After Market: | Before Market |
| Currency: | CHF |
| Eps Actual: | 6.66 |
| Eps Estimate: | 7.32 |
| Eps Difference: | -0.66 |
| Surprise Percent: | -9.01 |
| Report Date: | 2022-04-21 |
| Date: | 2022-03-31 |
| Currency: | CHF |
| Report Date: | 2022-02-01 |
| Date: | 2021-12-31 |
| Currency: | CHF |
| Eps Actual: | 5.55 |
| Eps Estimate: | 6.68 |
| Eps Difference: | -1.13 |
| Surprise Percent: | -16.91 |
| Report Date: | 2021-10-26 |
| Date: | 2021-09-30 |
| Currency: | CHF |
| Report Date: | 2021-07-23 |
| Date: | 2021-06-30 |
| Currency: | CHF |
| Eps Actual: | 3.5 |
| Eps Estimate: | 6.18 |
| Eps Difference: | -2.68 |
| Surprise Percent: | -43.36 |
| Report Date: | 2021-04-22 |
| Date: | 2021-03-31 |
| Currency: | CHF |
| Report Date: | 2021-01-26 |
| Date: | 2020-12-31 |
| Currency: | CHF |
| Eps Actual: | 3.38 |
| Eps Estimate: | 6.42 |
| Eps Difference: | -3.04 |
| Surprise Percent: | -47.35 |
| Report Date: | 2020-10-20 |
| Date: | 2020-09-30 |
| Currency: | CHF |
| Report Date: | 2020-07-23 |
| Date: | 2020-06-30 |
| Currency: | CHF |
| Eps Actual: | 6.39 |
| Eps Estimate: | 6.09 |
| Eps Difference: | 0.3 |
| Surprise Percent: | 4.92 |
| Report Date: | 2020-05-08 |
| Date: | 2020-03-31 |
| Currency: | CHF |
| Report Date: | 2020-01-21 |
| Date: | 2019-12-31 |
| Currency: | CHF |
| Eps Actual: | 4.96 |
| Eps Estimate: | 5.83 |
| Eps Difference: | -0.87 |
| Surprise Percent: | -14.92 |
| Report Date: | 2019-07-24 |
| Date: | 2019-06-30 |
| Currency: | CHF |
| Eps Actual: | 5.26 |
| Eps Estimate: | 6.23 |
| Eps Difference: | -0.97 |
| Surprise Percent: | -15.56 |
| Report Date: | 2019-01-30 |
| Date: | 2018-12-31 |
| Currency: | CHF |
| Eps Actual: | 3.38 |
| Eps Estimate: | 5.87 |
| Eps Difference: | -2.49 |
| Surprise Percent: | -42.41 |
| Report Date: | 2018-07-25 |
| Date: | 2018-06-30 |
| Currency: | CHF |
| Eps Actual: | 5.39 |
| Eps Estimate: | 4.17 |
| Eps Difference: | 1.22 |
| Surprise Percent: | 29.25 |
| Report Date: | 2018-05-04 |
| Date: | 2018-03-31 |
| Currency: | CHF |
| Report Date: | 2018-01-31 |
| Date: | 2017-12-31 |
| Currency: | CHF |
| Eps Actual: | 6.55 |
| Eps Estimate: | 5.09 |
| Eps Difference: | 1.46 |
| Surprise Percent: | 28.68 |
| Report Date: | 2017-04-26 |
| Date: | 2017-03-31 |
| Currency: | CHF |
| Report Date: | 2017-01-25 |
| Date: | 2016-12-31 |
| Currency: | CHF |
| Eps Actual: | 1.86 |
| Eps Difference: | 1.86 |
| Report Date: | 2016-07-20 |
| Date: | 2016-06-30 |
| Currency: | CHF |
| Eps Actual: | 3.43 |
| Eps Estimate: | 3.6 |
| Eps Difference: | -0.17 |
| Surprise Percent: | -4.72 |
| Report Date: | 2016-01-27 |
| Date: | 2015-12-31 |
| Currency: | CHF |
| Eps Actual: | 2.91 |
| Eps Difference: | 2.91 |
| Report Date: | 2015-07-22 |
| Date: | 2015-06-30 |
| Currency: | CHF |
| Eps Estimate: | 2.53 |
| Eps Difference: | -2.53 |
| Surprise Percent: | -10 |
| Report Date: | 2015-01-21 |
| Date: | 2014-12-31 |
| Currency: | CHF |
| Eps Estimate: | 2.82 |
| Eps Difference: | -2.82 |
| Surprise Percent: | -10 |
| Report Date: | 2014-07-24 |
| Date: | 2014-06-30 |
| Currency: | CHF |
| Report Date: | 2014-01-23 |
| Date: | 2013-12-31 |
| Currency: | CHF |
| Eps Estimate: | 2.29 |
| Eps Difference: | -2.29 |
| Surprise Percent: | -10 |
| Date: | 2023-12-31 |
| Period: | +1y |
| Growth: | 0.18 |
| Earnings Estimate Avg: | 18.03 |
| Earnings Estimate Low: | 17.22 |
| Earnings Estimate High: | 20.04 |
| Earnings Estimate Year Ago Eps: | 15.19 |
| Earnings Estimate Number Of Analysts: | 16.00 |
| Earnings Estimate Growth: | 0.18 |
| Revenue Estimate Avg: | 6939490000.00 |
| Revenue Estimate Low: | 6729000000.00 |
| Revenue Estimate High: | 7279740000.00 |
| Revenue Estimate Number Of Analysts: | 19.00 |
| Revenue Estimate Growth: | 0.11 |
| Eps Trend Current: | 18.03 |
| Eps Trend7days Ago: | 18.03 |
| Eps Trend30days Ago: | 18.01 |
| Eps Trend60days Ago: | 17.89 |
| Eps Trend90days Ago: | 18.10 |
| Eps Revisions Up Last30days: | 2.00 |
| Date: | 2022-12-31 |
| Growth: | 0.20 |
| Earnings Estimate Avg: | 15.19 |
| Earnings Estimate Low: | 14.38 |
| Earnings Estimate High: | 16.70 |
| Earnings Estimate Year Ago Eps: | 12.63 |
| Earnings Estimate Number Of Analysts: | 16.00 |
| Earnings Estimate Growth: | 0.20 |
| Revenue Estimate Avg: | 6203460000.00 |
| Revenue Estimate Low: | 6013000000.00 |
| Revenue Estimate High: | 6401000000.00 |
| Revenue Estimate Number Of Analysts: | 19.00 |
| Revenue Estimate Growth: | 0.14 |
| Eps Trend Current: | 15.19 |
| Eps Trend7days Ago: | 15.19 |
| Eps Trend30days Ago: | 15.22 |
| Eps Trend60days Ago: | 15.22 |
| Eps Trend90days Ago: | 15.43 |
| Eps Revisions Up Last30days: | 1.00 |
| Eps Revisions Down Last30days: | 1.00 |
| Date: | 2022-09-30 |
| Date: | 2022-06-30 |
| Date: | 2019-12-31 |
| Period: | +1y |
| Revenue Estimate Avg: | 6376940000.00 |
| Revenue Estimate Low: | 5922070000.00 |
| Revenue Estimate High: | 6557430000.00 |
| Revenue Estimate Number Of Analysts: | 15.00 |
| Revenue Estimate Growth: | 0.05 |
| Eps Trend7days Ago: | 13.73 |
| Eps Trend30days Ago: | 13.73 |
| Eps Trend60days Ago: | 13.73 |
| Eps Trend90days Ago: | 13.73 |
| Eps Revisions Down Last7days: | 1.00 |
| Eps Revisions Down Last30days: | 1.00 |
| Date: | 2019-03-31 |
| Period: | +1q |
| Date: | 2018-12-31 |
| Revenue Estimate Avg: | 6044030000.00 |
| Revenue Estimate Low: | 5521000000.00 |
| Revenue Estimate High: | 6148100000.00 |
| Revenue Estimate Number Of Analysts: | 15.00 |
| Revenue Estimate Growth: | 0.18 |
| Eps Trend7days Ago: | 12.19 |
| Eps Trend30days Ago: | 12.19 |
| Eps Trend60days Ago: | 12.19 |
| Eps Trend90days Ago: | 12.19 |
| Eps Revisions Up Last30days: | 1.00 |
| Eps Revisions Down Last7days: | 1.00 |
| Eps Revisions Down Last30days: | 1.00 |
| Date: | 2024-03-31 |
| Date: | 2022-12-31 |
| Eps Actual: | 2 |
| Date: | 2021-12-31 |
| Eps Actual: | 9.0 |
| Date: | 2020-12-31 |
| Eps Actual: | 9.7 |
| Date: | 2019-12-31 |
| Eps Actual: | 10.2 |
| Date: | 2018-12-31 |
| Eps Actual: | 8.7 |
| Date: | 2017-12-31 |
| Eps Actual: | 6.5 |
| Date: | 2016-12-31 |
| Eps Actual: | 5.2 |
| Date: | 2015-12-31 |
| Eps Actual: | 2.9 |
| Date: | 2014-12-31 |
| Date: | 2013-12-31 |